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Abstract: It is commonly accepted that bone marrow-derived stem cells (BMSCs) have to be expanded in vitro, but a 
prolonged time in culture decreases their multilineage potential. Mechanical and biological stimuli have been used to 
improve their osteogenic potential. While long-term stimulation has been shown to improve osteogenic differentiation, it 
remains to be seen whether short-term stimulation is also sufficient. 
We investigated the influence of 24 hours' cyclic loading (0.05Hz, 4kPa) on gene expression of human BMSCs in three-
dimensional fibrin-DMEM constructs (n=7) in a compression bioreactor using DNA-array technology. Expression of the 
following genes showed a significant increase after mechanical stimulation: 2.6-fold osteopontin (OPN) and integrin-1 
(ITGB1), 2.2-fold transforming growth factor--receptor 1 (TGF--R1) and 2.4-fold SMAD5 expression, compared to 
controls without mechanical stimulation (p<0.05 each). Platelet-derived growth factor- (PDGF-) and annexin-V were 
also significantly overexpressed, the mechanical stimulation resulting in a 1.8-fold and 1.6-fold expression (p<0.05). 
Cells were identified as osteoblast precursors with a high proliferative capacity. Given the identical in-vitro environment 
for both groups, the increase in gene expression has been interpreted as a direct influence of cyclic mechanical stimulation 
on osteogenic differentiation. It may be postulated that short-term mechanical stimulation results in an improved osseous 
integration of tissue engineered grafts in bone defect healing. 
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INTRODUCTION 
  Major bone defects remain an unsolved therapeutic 
problem in orthopaedic surgery, especially in revision 
arthroplasty, treatment of pseudarthrosis or after tumour 
resections [1]. The use of autologous and allogenic bone 
grafts is the most widely used regenerative approach [2]. 
Fundamental differences in biology have been noted in these 
two approaches: Allografts demonstrate only osteoconduc-
tive capacity with low overall integration and an unsatis-
factory long-term clinical outcome [3-5]. Autografts show 
osteoinductive and osteogenic characteristics, leading to 
significantly better clinical results [6]. However, their use is 
limited by restricted availability and significant donor-site 
morbidity [7]. 
  A therapeutic approach that harnesses the osteogenic 
potential of autografts, without the limitations of low 
availability and high donor-site morbidity is still missing in 
the treatment of bone defects. 
  Therefore, autologous osteogenic cells like periosteum-
derived cells in different matrices have been investigated in 
regenerative bone defect therapy and promising results have 
been published [8, 9]. Bone marrow-derived stromal cells 
have also been investigated in animal and clinical trials, an 
accelerated healing of bone defects being reported [10-13]. 
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  BMSCs have little donor-site morbidity and are easily 
expanded in vitro [14], but their multilineage potential and 
proliferative capacity decreases with time in vitro [15]. It has 
therefore been recommended to keep the in-vitro phase as 
short as possible in clinical situations [16, 17]. A prediffer-
entiation of cells during the in-vitro period has been reported 
to be beneficial, as the osteogenic potential of BMSCs can 
be augmented through biological or mechanical stimulation 
lasting for several weeks [18, 19]. 
  In the present study we wanted to investigate whether a 
short-term mechanical stimulation of just 24 hours is 
sufficient to achieve an osteogenic predifferentiation in vitro. 
A short period of stimulation and thereby short in-vitro time 
might be advantageous for subsequent in-vivo use. 
Maintaining the high proliferative capacity and directing the 
cellular differentiation into an osteogenic lineage may 
improve results of cell-based approaches in the treatment of 
bone defects. 
MATERIALS AND METHODOLOGY 
Study Design 
  BMSCs were harvested from seven different donors, all 
cells then being expanded separately in cell-culture flasks. 
After a sufficient amount of cells had been achieved, they 
were transferred into three-dimensional constructs consisting 
of an elastic fibrin-DMEM matrix and then put between two 
slices of freeze-dried cancellous bone. All constructs were 
placed in bioreactors, as described previously [20]. Half of 
the constructs underwent cyclic mechanical compression; the 
other half remained without mechanical stimulation as a 2    The Open Orthopaedics Journal, 2011, Volume 5  Matziolis et al. 
control. The gene expression in mechanically stimulated 
cells was normalized versus unstimulated controls. 
Cells and Cell Culture 
  The BMSCs were gained from aspirates of the proximal 
femur during total hip arthroplasty operations. All 7 donors 
(4 female, 3 male, average age 61 years) gave informed 
consent. A pre-existing bone disease was excluded 
anamnestically and by bone densitometry investigation 
(Lunar-DPX, USA). Approximately 5ml bone-marrow 
aspirate were harvested from the intertrochanteric region of 
the proximal femur, and kept at 8°C until further processing 
within 4 hours. 
  Density centrifugation was performed (Histopaque 
1.077g - Sigma-Aldrich, Germany) for 15 minutes at 
1500rpm. The interphase containing the BMSCs was 
transferred into culture medium (DMEM + 10% FCS 
[Biochrome, Germany] + 100U/ml penicillin + 100g/ml 
streptomycin [Sigma-Aldrich, Germany]). The cells were 
dispersed in culture flasks (Falcon, Greiner, Germany) and 
then incubated at 37°C and 5% CO2. Passage into a new 
flask was performed at approximately 70% confluence. 
3D Matrix/Bone-Fibrin-DMEM Constructs 
  After having reached passage 3 in the above given cell 
culture medium, cells were transferred into 3D constructs, 
consisting of a fibrin-DMEM-mix matrix and placed 
between two slices of freeze-dried human cancellous bone. 
Every construct contained 1x10
6 cells in 600l DMEM + 
10%FCS (Biochrome, Germany) + 100U/ml penicillin + 
100g/ml streptomycin (Sigma-Aldrich, Germany) + 2.4% 
aprotinin (Bayer, Germany). For polymerization 30l 
fibrinogen and 1IU/ml thrombin (Aventis, Germany) were 
added. The matrices hardened for one hour at 37°C at 5% 
CO2, before being transferred into the bioreactors. 
  The freeze-dried cancellous bone slices measured 15mm 
in diameter and 4mm in depth. Prior to construct mounting, 
they were rehydrated for two hours in culture medium. 
Mechanical Stimulation in the Compression Bioreactor 
  The principle of the compression bioreactor (Fig. 1) has 
been described previously [20]. A closed cylindrical 
polyethylene chamber communicates with the incubator via 
four sterile filters (0.2m pore diameter). The cell-matrix 
constructs were mechanically stimulated between two 
flexible silicon membranes. While the upper membrane 
loads the construct (Fig. 2) perpendicularly to its surface, the 
lower membrane transfers the pressure via  a standard 
infusion tube to a pressure transducer. 
  In the present experiment, we applied a cyclical pressure 
of 4kPa, resulting in a deformation of approximately 1mm 
(h/h=25%), at a frequency of 0.05Hz. The loading 
environment of the lower extremities during physiological 
activities such as walking and running is cyclic [21], and the 
frequency used in our experiment has been described to be 
within physiological conditions [22]. Control constructs 
(n=7) were cultivated in bioreactors without mechanical 
stimulation. After 24 hours, the cyclic compression was 
terminated and the constructs were harvested. 
 
RNA Extraction and Gene Expression 
 
Fig. (1). Compression bioreactor for cyclic loading of the constructs 
under sterile culture conditions. 
 
Fig. (2). Construct with BMDSCs in a fibrin matrix. 
  RNA isolation was started within two minutes. Under 
sterile conditions the fibrin-DMEM matrices were harvested 
from the compression bioreactors: the matrix was dissected 
sharply from the cancellous bone and transferred 
immediately into 2ml RNA-extraction solution (Trifast, 
Peqlab, Germany). Matrices were homogenized mechanically 
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(Ultra-Turrax-T8, IKA, Germany) directly afterwards. The 
RNA extraction was performed according to the protocol of 
the supplier. RNA integrity was controlled in a Bio Sizing 
Assay (Eukaryote Total RNA Nano, Agilent Technologies 
2100 Bioanalyzer, Germany). After measurement of total 
RNA using a photometer, the RNA was stored at -140°C 
until further use. 
  The expression of osteogenesis-specific genes was inves-
tigated using the GEArray-Q-Series Human Osteogenesis 
Gene Array (Biomol, Germany). 3-3.5g total RNA was 
used for each array. cDNA synthesis was accomplished at 
37°C for 25 minutes. The subsequent labelling was carried 
out with Biotin-16-dUTP (Roche, Germany) and an ampli-
fication labelling kit (Biomol, Germany) according to the 
protocol of the supplier. 30 cycles of PCR amplification 
were implemented, with 85°C, 50°C and 72°C for 1 minute 
each (MJ Research Inc, USA). Hybridisation of the PCR 
product on the arrays was carried out at 56°C for 12 hours. 
Unspecific binding had been blocked by prehybridisation 
with salmon-sperm DNA (Roche Diagnostics, Germany) for 
2 hours. After labelling with streptavidin-biotin antibodies 
and addition of CDP-Star solution (Biomol, Germany), the 
array signal was transmitted onto x-ray films (Kodak, 
Germany). Films were developed and scanned. The gene 
expression was analyzed using the programs ScanAlyze 
Version 2.5 (Eisen Software, USA) and GEArray Analyzer 
1.3 (Superarray, USA). Following the recommendation of 
the array supplier, genes with unreliably low signals were 
excluded from further analysis. 
STATISTICS 
  Statistical analysis was performed using SPSS 12.0. After 
background subtraction, the signals were normalized to the 
GAPDH as house keeping gene. The evaluation was carried 
out comparing directly the expression of mechanical 
stimulated cells versus controls of one donor. The 
expressions of the controls were defined as 1. All 
experiments were done in triplicate for all the 7 patients, all 
samples were subjected to DNA array analysis. A Wilcoxon 
signed rank test was carried out for statistical testing, a level 
of significance of p=0.05 was chosen. 
RESULTS 
  The RNA isolation was successful in all cases; all 
specimens could be included in the data analysis (Table 1). 
We noted a strong expression of core-binding-factor-1 
(Cbfa1) in all BMSCs, showing no significant difference 
between the two treatment groups (p=0,463). We found 
significant differen-ces in the expression of mechanically 
stimulated BMSCs compared to controls, as shown in Fig. 
(3). 
Matrix Proteins 
  A significant difference was noted for the expression of 
the osteopontin (OPN) gene, which showed a 2.6-fold 
expression in mechanically stimulated cells, compared to 
controls (p=0.043). 
Cell-Surface Receptors 
  Furthermore, we found a 2.6-fold increase in the 
expression of the integrin--1 gene and a 2.2-fold increase in 
the expression of the transforming-growth-factor-beta-
receptor 1 (TGF--R1), both differences being significant 
(p=0.018). 
Intracellular Signalling Molecule 
  The mechanical stimulation also had a direct effect on the 
expression of an intracellular signal molecule, the SMAD-5 
gene, which showed a 2.4-fold increase (p=0.028). 
  Moreover, we found significant increases of two other 
genes: 1.8-fold for platelet-derived growth factor-alpha 
(PDGF-) (p=0.027) and 1.6-fold for annexin-V (p= 0.034). 
DISCUSSION 
  BMSCs show high proliferative capacity and do not 
undergo terminal osteoblast differentiation in vitro without 
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external stimulation. In the present study, we could show for 
the first time that 24 hours of cyclic compression is able to 
increase the expression of several osteogenesis-specific 
genes and thereby lead to an osteogenic predifferentiation of 
BMSCs. 
  The gene expression analysis showed a marked 
expression of Cbfa1, the master control gene of osteoblastic 
differentiation [23]. The BMSCs shifted to the level of 
immature osteoprogenitors [24]. 
  By definition, these cells do not yet show expression of 
the typical markers for osteogenesis, like osteocalcin, 
alkaline phosphatase or type-I collagen, which were not 
detectable in our trial. However, they do express the non-
collagenous matrix protein osteopontin [25], which was 
significantly increased by mechanical stimulation in our 
Table 1  Mean Changes in mRNA Expression of BMDSCs Through 24h of Mechanical Stimulation Normalized Versus Control 
Group w/o Mechanical Stimulation Measured with a Human Osteogenesis Gene Array (Biomol, Germany) 
 
Gene Xfold  Increase Gene Xfold  Increase Gene Xfold  Increase 
alk.  phosphatase  0 COL7A1 0 SMAD9  1.5 
annexin v  1.6  COL9A2  1.3  MMP10  1.3 
ARSE 0  GM-CSF  0  collagenase-3  0.9 
Osteocalcin  0  G-CSF  0.3 gelatinase  A 0.9 
Biglycan  1.6 CTSK 1.1 MMP8 0.1 
BMP1  0 Decorin 1  gelatinase  B  1 
BMP2  0 EGF 0  Hox7  0.6 
BMP3 0.1 EGFR 1.1 MSX2  0 
BMP 4  0  FGF1  0.1  NFkB  0.4 
BMP5 0 FGF2 0  PDGFa  1.8 
BMP  6  0 FGF3(int-2) 0  CBFA1  1 
BMP7 0  FGFR1  (FLG)  0.5  CBP1  0.9 
BMP  8 0.6 FGFR2  0  CBP2  0.1 
ALK-3 0.6 FGFR3 0.2  SOX9  0 
CASR 0.1  FLT1  0  SPARC  cleav.  prod.  1.1 
CD36  0.5  fibronectin-1  0.8 OPN 2.6 
CD36L1 1.3 BMP3B  0  TGFb1  0 
CD36L2 -0.1 ICAM-1  0  TGF  b2  0 
COL10A1 0.3  IGF-1  0.9  TGF  b3  1.4 
COL11A1 1.7  IGF-1R  0  TGFBR1  2.2 
COL12A1 1.1  IGF-II  0  TGFbR2  0.3 
COL14A1 0.8 Integrin  a1 1.5  TNFa  1.5 
COL15A1 0 Integrin  a2  0.7  TWIST  0.3 
COL16A1 1.3 Integrin  a3 1.3  VCAM-1  0.1 
COL17A1 0.3  Integrin  aM 0  VDR  0 
Endostatin 0.6 Integrin  aV 0.3  VEGF  0 
COL19A1 0 Integrin  b1  2.6 VEGF-B 1.3 
COL1A1 0 SMAD1  0.9  VEGF-C  1.3 
COL2A1 1.1  SMAD2 1.1  pUC18  0.1 
COL3A1 1.4  SMAD3 1.3  0  0 
COL4A3 0  DPC4/SMAD4  0.4  GAPDH 1 
COL4A4 0 SMAD5  2.4  cyclophilin  A  2.3 
COL4A5 0 SMAD6 0 RPL13A  0.9 
COL5A1 1.1  SMAD7 0.8  b-actin  0.6 Osteogenic Predifferentiation of Human Bone Marrow-Derived Stem Cells  The Open Orthopaedics Journal, 2011, Volume 5    5 
setting. It might be hypothesized that more BMSCs were 
directed towards immature osteoprogenitors. 
  As a non-collagenous protein of the bone matrix, OPN 
has further influences on bone metabolism: amongst others, 
it plays an important role during bone remodelling, 
inflammation and under mechanical stress [25, 26]. An 
elevated OPN expression has also been noted during the 
early phase of fracture healing, prior to callus formation. As 
Kawahata and co-worker hypothesized that it might be a 
trigger for osteogenesis [27], the increased expression of 
OPN after 24 hours of cyclic compression may be an 
indicator of initial osteogenesis. 
  Another important effect of OPN has been identified in 
mice: ectopically implanted autologous bone showed lower 
transplant vascularization and integration, due to reduced 
bone remodelling [28]. A 2.6-fold increase of OPN 
expression by mechanical stimulation of constructs with 
BMSCs might thus augment bone remodelling and improve 
transplant vascularization and integration. 
  The mechanically stimulated BMSCs also showed an 
increased expression of integrin-1, a part of transmembrane 
glycoprotein that forms heterodimers with integrin- 
subunits and links the cytoskeleton to the extracellular 
matrix. The importance of integrin-1 in osteogenesis and 
osteoblast function has been shown in mice [29]. Together 
with the 1-3 subunits, it binds to collagen, and ligand-
binding leads to increased expression of osteoblast markers 
[30, 31]. The 1-subunit has been identified as the most 
important integrin in the development of BMSCs to 
osetoblasts [32]. Its increased expression might signalize the 
promotion of osteogenic differentiation in BMSCs following 
24 hours of mechanical stimulation. 
  In addition, the mechanically stimulated BMSCs showed 
a significant increase in the expression of the TGF-ß-
receptor1 [33]. This receptor has been identified on 
osteoprogenitor cells and also on terminally differentiated 
osteoblasts [34]. Its ligand TGF-ß has been shown to be 
involved in the regulation of proliferation and migration of 
progenitor cells and leads to an increase of osteoblastic 
differentiation, independently of their differentiation state 
[35]. It promotes osteogenic differentiation in BMSCs, with 
enhanced matrix synthesis and calcification [36, 37]. The 
mechanically stimulated BMSCs with an increased 
expression of the TGF--receptor1 might therefore be more 
sensitive to TGF-ß stimuli and show augmented osteogenic 
differentiation when implanted into bone defects. 
  The increase of the intracellular signal molecule Smad-5 
may be another indicator of osteogenic predifferentiation. 
Smad-5 interacts with Smad-1 and mediates signals from 
cytokines of the TGF-ß superfamily, and among them the 
osteoblastic differentiation of progenitor cells [38, 39]. This 
may result in a facilitation of osteogenic differentiation of 
mechanically stimulated cells in bone defects. 
  The expression of the growth factor PDGF- also 
increased following mechanical stimulation. PDGF- is 
known to induce osteogenic differentiation, has additional 
chemotactic effects on osteoprogenitor cells and enhances 
the proliferation of osteoblasts [40]. These are all effects that 
may contribute to improved results following mechanical 
stimulation of BMSCs before using them in cell-based 
therapies. 
  Annexin-V gene expression was significantly increased 
after mechanical stimulation. Annexin-V protein builds Ca
2+ 
channels, leading to mineralization of bone matrix in the 
growth plates during osteogenesis [41]. An increased 
expression of annexin-V enhances these processes of 
mineralization [42]. Such mineralization processes were 
observed in a prior study, whereas periosteal cells underwent 
long-term mechanical stimulation in bioreactors [20]. 
CONCLUSION 
  In recent years, different methods have been developed to 
stimulate osteogenic differentiation of BMSCs in vitro an in 
vivo, like medium supplements, growth factors or viral 
transfection [1, 43]. The approach of mechanical stimulation 
presented here is advantageous, because it can be directly 
transferred to clinical application. The selected fibrin matrix 
allows temporary fixation of BMSCs in a bone defect and 
has shown excellent biocompatibility [8, 44]. 
  Our results show a concomitant increase of genes coding 
for matrix molecules, receptors and growth factors by 
mechanical stimulation. The presented data indicate that 24 
hours are sufficient to obtain changes in gene expression, 
resulting in an osteogenic predifferentiation of BMSCs. The 
shift towards immature osteoprogenitor cells combines the 
desired high proliferative capacity with an osteogenic 
potential that makes them a promising tool in cell-based 
treatment of bone defects. It may be postulated that short-
term mechanical stimulation will result in an improved 
osseous integration of tissue engineered grafts in bone defect 
healing. 
REFERENCES 
[1]  Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state 
of the art and future trends. Macromol Biosci 2004; 4: 743-65. 
[2]  Yan MN, Dai KR, Tang TT, Zhu ZA, Lou JR. Reconstruction of 
peri-implant bone defects using impacted bone allograft and BMP-
2-gene-modified bone marrow stromal cells. J Biomed Mater Res 
A 2010; 933(1): 304-13. 
[3]    Brown KL, Cruess RL. Bone and cartilage transplantation in 
orthopaedic surgery. A review. J Bone Joint Surg Am 1982; 64: 
270-9. 
[4]    Hooten JP Jr., Engh CA, Heekin RD, Vinh TN. Structural bulk 
allografts in acetabular reconstruction. Analysis of two grafts 
retrieved at post-mortem. J Bone Joint Surg Br 1996; 78: 270-5. 
[5]  Kwong LM, Jasty M, Harris WH. High failure rate of bulk femoral 
head allografts in total hip acetabular reconstructions at 10 years. J 
Arthroplasty 1993; 8: 341-6. 
[6]   Rose LJ. Autologous bone marrow transplants. Health Aff 2002; 
21: 308. 
[7]   Younger EM, Chapman MW. Morbidity at bone graft donor sites. J 
Orthop Trauma 1989; 3: 192-5. 
[8]   Perka C, Arnold U, Spitzer RS, Lindenhayn K. The use of fibrin 
beads for tissue engineering and subsequential transplantation. 
Tissue Eng 2001; 7: 359-61. 
[9]   Spitzer RS, Perka C, Lindenhayn K, Zippel H. Matrix engineering 
for osteogenic differentiation of rabbit periosteal cells using alpha-
tricalcium phosphate particles in a three-dimensional fibrin culture. 
J Biomed Mater Res 2002; 59: 690-6. 
[10]   Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large 
bone defects with the use of autologous bone marrow stromal cells. 
N Engl J Med 2001; 344: 385-6. 
[11]   Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of 
implants loaded with autologous mesenchymal stem cells on the 
healing of canine segmental bone defects. J Bone Joint Surg Am 
1998; 80: 985-96. 6    The Open Orthopaedics Journal, 2011, Volume 5  Matziolis et al. 
[12]    Kon E, Muraglia A, Corsi A, et al. Autologous bone marrow 
stromal cells loaded onto porous hydroxyapatite ceramic accelerate 
bone repair in critical-size defects of sheep long bones. J Biomed 
Mater Res 2000; 49: 328-37. 
[13]  Braccini A, Wendt D, Farhadi J, Schaeren S, Heberer M, Martin I. 
The osteoenicity of implanted engineered bone constructs is related 
to the density of clonogenic bone marrow stromal cells. J Tissue 
Eng Regen Med 2007; 1: 60-5. 
[14]    Prockop, DJ. Marrow stromal cells as stem cells for 
nonhematopoietic tissues. Science 1997; 276: 71-4. 
[15]   Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto, R. 
Replicative aging and gene expression in long-term cultures of 
human bone marrow stromal cells. Tissue Eng 2002; 8: 901-10. 
[16]   Derubeis, AR, Cancedda R. Bone marrow stromal cells (BMSCs) 
in bone engineering: limitations and recent advances. Ann Biomed 
Eng 2004; 32: 160-5. 
[17]   Cancedda R, Mastrogiacomo M, Bianchi G, Derubeis A, Muraglia 
A, Quarto R. Bone marrow stromal cells and their use in 
regenerating bone. Novartis Found Symp 2003; 249: 133-43. 
[18]   Ng AM, Saim AB, Tan KK, et al. Comparison of bioengineered 
human bone construct from four sources of osteogenic cells. J 
Orthop Sci 2005; 10: 192-9. 
[19]   Mauney JR, Sjostorm S, Blumberg J, et al. Mechanical stimulation 
promotes osteogenic differentiation of human bone marrow stromal 
cells on 3-D partially demineralized bone scaffolds in vitro. Calcif 
Tissue Int 2004; 74: 458-68. 
[20]    Matziolis G, Tuischer J, Kasper G, et al. Simulation of cell 
differentiation in fracture healing-mechanically loaded composite 
scaffolds in a novel bioreactor system. Tissue Eng 2006; 12: 201-8. 
[21]   Paul JP, McGrouther DA. Forces transmitted at the hip and knee 
joint of normal and disabled persons during a range of activities. 
Acta Orthop Belg 1975; 41 Suppl 1: 78-88. 
[22]   Krishnan R, Mariner EN, Ateshian GA. Effect of dynamic loading 
on the frictional response of bovine articular cartilage. J Biomech 
2005; 38: 1665-73. 
[23]    Schinke T, Karsenty G. Transcriptional control of osteoblast 
differentiation and function. In: Bilezikan JP, Raisz LG, Rodan 
GA, Eds. Principles of Bone Biology. 2
nd ed, San Diego: Academic 
Press 2001; pp. 83-91. 
[24]    Aubin JE, Triffit JT. Mesenchymal stem cells and osteoblast 
differentiation. In: Bilezikan, JP, Raisz LG, Rodan GA, Eds. 
Principles of Bone Biology. 2
nd ed, San Diego: Academic Press 
2001; pp. 59-81. 
[25]   Mark MP, Prince CW, Gay S, et al. A comparative immunocyto-
chemical study on the subcellular distributions of 44 kDa bone 
phosphoprotein and bone gamma-carboxyglutamic acid (Gla)-
containing protein in osteoblasts. J Bone Miner Res 1987; 2: 337-
46. 
[26]   Noda M, Denhardt DT. Osteopontin. In: Bilezikan, JP, Raisz LG, 
Rodan GA, Eds. Principles of Bone Biology. 2
nd ed. San Diego: 
Academic Press 2001; pp. 239-50. 
[27]    Kawahata H, Kikkawa T, Higashibata Y, et al. Enhanced 
expression of Runx2/PEBP2alphaA/CBFA1/AML3 during fracture 
healing. J Orthop Sci 2003; 8: 102-8. 
[28]   Asou Y, Rittling SR, Yoshitake, H, et al. Osteopontin facilitates 
angiogenesis, accumulation of osteoclasts, and resorption in ectopic 
bone. Endocrinology 2001; 142: 1325-32. 
[29]   Zimmerman D, Jin F, Leboy P, Hardy S, Damsky C. Impaired bone 
formation in transgenic mice resulting from altered integrin 
function in osteoblasts. Dev Biol 2000; 220: 2-15. 
[30]   Horton MA. Integrin antagonists as inhibitors of bone resorption: 
implications for treatment. Proc Nutr Soc 2001; 60: 275-81. 
[31]   Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. Role of 
the alpha2-integrin in osteoblast-specific gene expression and 
activation of the Osf2 transcription factor. J Biol Chem 1998; 273: 
32988-94. 
[32]  Gronthos S, Simmons PJ, Graves SE, Robey PG. Integrin-mediated 
interactions between human bone marrow stromal precursor cells 
and the extracellular matrix. Bone 2001; 28: 174-81. 
[33]  Huang CY, Reuben PM, Cheung HS. Temporal expression patterns 
and corresponding protein inductions of early responsive genes in 
rabbit bone marrow-derived mesnchymal stem cells under cyclic 
compressive loading. Stem Cells 2005; 23: 1113-21. 
[34]   Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella 
M. Reduction in transforming growth factor beta receptor I 
expression and transcription factor CBFa1 on bone cells by 
glucocorticoid. J Biol Chem 1998; 273: 4892-6. 
[35]    Kassem M, Kveiborg M, Eriksen EF. Production and action of 
transforming growth factor-beta in human osteoblast cultures: 
dependence on cell differentiation and modulation by calcitriol. Eur 
J Clin Invest 2000; 30: 429-37. 
[36]    Lieb E, Milz S, Vogel, T, Hacker M, Dauner M, Schulz MB. 
Effects of transforming growth factor beta1 on bonelike tissue 
formation in three-dimensional cell culture. I. Culture conditions 
and tissue formation. Tissue Eng 2004; 10:1399-413. 
[37]    Lieb E, Vogel T, Milz S, Dauner M, Schulz MB. Effects of 
transforming growth factor beta1 on bonelike tissue formation in 
three-dimensional cell culture. II: Osteoblastic differentiation. 
Tissue Eng 2004; 10: 1414-25. 
[38]   Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T. 
Smad5 and DPC4 are key molecules in mediating BMP-2-induced 
osteoblastic differentiation of the pluripotent mesenchymal 
precursor cell line C2C12. J Biol Chem 1998; 273: 1872-9. 
[39]    Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic 
responses to TGF-beta during bone remodeling. Mol Biol Cell 
1998; 9: 1903-18. 
[40]   Fiedler J, Etzel N, Brenner RE. To go or not to go: Migration of 
human mesenchymal progenitor cells stimulated by isoforms of 
PDGF. J Cell Biochem 2004; 93: 990-8. 
[41]   Plate U, Tkotz T, Wiesmann HP, Stratmann U, Joos U, Hohling 
HJ. Early mineralization of matrix vesicles in the epiphyseal 
growth plate. J Microsc 1996; 183: 102-7. 
[42]   Wang W, Xu J, Kirsch T. Annexin V and terminal differentiation 
of growth plate chondrocytes. Exp Cell Res 2005; 305: 156-65. 
[43]    Gazit D, Turgeman G, Kelley P, et al. Engineered pluripotent 
mesenchymal cells integrate and differentiate in regenerating bone: 
a novel cell-mediated gene therapy. J Gene Med 1999; 1: 121-33. 
[44]   Arnold U, Schweitzer S, Lindenhayn K, Perka C. Optimization of 
bone engineering by means of growth factors in a three-
dimensional matrix. J. Biomed Mater Res A 2003; 67: 260-9. 
 
 
Received: April 21, 2010  Revised: July 8, 2010  Accepted: July 19, 2010 
 
© Matziolis et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
 